ReP USP - Resultado da busca

Artigo de periodico
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination (2023)
Smaira, Fabiana Infante ; Mazzolani, Bruna Caruso ; Lemes, Ítalo Ribeiro ; Silva, Rafael Pires da ; Pinto, Ana J ; Sieczkowska, Sofia M ; Aikawa, Nadia E ; Pasoto, Sandra G ; Medeiros-Ribeiro, Ana C ; Saad, Carla G. S ; Yuki, Emily F. N ; Silva, Clovis A ; Swinton, Paul ; Kupa, Leonard de Vinci Kanda ; Hallal, Pedro Curi ; Roschel, Hamilton ; Gualano, Bruno ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Journal of Physical Activity and Health. Unidades: FM, EEFE
Subjects: COVID-19, ATIVIDADE FÍSICA, VACINAS, IMUNOSSUPRESSÃO, DOENÇAS REUMÁTICAS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SMAIRA, Fabiana Infante et al. No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination. Journal of Physical Activity and Health, v. 20, n. 10, p. 980-983, 2023Tradução . . Disponível em: https://doi.org/10.1123/jpah.2022-0362. Acesso em: 04 set. 2024.
APA
Smaira, F. I., Mazzolani, B. C., Lemes, Í. R., Silva, R. P. da, Pinto, A. J., Sieczkowska, S. M., et al. (2023). No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination. Journal of Physical Activity and Health, 20( 10), 980-983. doi:10.1123/jpah.2022-0362
NLM
Smaira FI, Mazzolani BC, Lemes ÍR, Silva RP da, Pinto AJ, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Silva CA, Swinton P, Kupa L de VK, Hallal PC, Roschel H, Gualano B, Bonfa ESD de O. No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination [Internet]. Journal of Physical Activity and Health. 2023 ; 20( 10): 980-983.[citado 2024 set. 04 ] Available from: https://doi.org/10.1123/jpah.2022-0362
Vancouver
Smaira FI, Mazzolani BC, Lemes ÍR, Silva RP da, Pinto AJ, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Silva CA, Swinton P, Kupa L de VK, Hallal PC, Roschel H, Gualano B, Bonfa ESD de O. No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination [Internet]. Journal of Physical Activity and Health. 2023 ; 20( 10): 980-983.[citado 2024 set. 04 ] Available from: https://doi.org/10.1123/jpah.2022-0362
Artigo de periodico
Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus (2022)
Yuki, Emily F. N; Borba Neto, Eduardo Ferreira ; Pasoto, Sandra G; Seguro, Luciana P; Lopes, Michelle; Saad, Carla G. S; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Arthritis care & research. Unidade: FM
Subjects: ANTICORPOS, VACINAS VIRAIS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKI, Emily F. N et al. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, v. 74, n. 4, p. 562-571, 2022Tradução . . Disponível em: https://doi.org/10.1002/acr.24824. Acesso em: 04 set. 2024.
APA
Yuki, E. F. N., Borba Neto, E. F., Pasoto, S. G., Seguro, L. P., Lopes, M., Saad, C. G. S., et al. (2022). Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, 74( 4), 562-571. doi:10.1002/acr.24824
NLM
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 set. 04 ] Available from: https://doi.org/10.1002/acr.24824
Vancouver
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 set. 04 ] Available from: https://doi.org/10.1002/acr.24824
Artigo de periodico
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome (2022)
Signorelli, Flavio; Balbi, Gustavo Guimaraes Moreira; Aikawa, Nadia E; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Medeiros-Ribeiro, Ana C; Yuki, Emily F. N; Pasoto, Sandra G; Saad, Carla G. S; Borba Neto, Eduardo Ferreira ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Lupus. Unidade: FM
Subjects: COVID-19, ANTICORPOS ANTIFOSFOLIPÍDEOS, IMUNOGENÉTICA, FATORES DE RISCO, COAGULAÇÃO SANGUÍNEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIGNORELLI, Flavio et al. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. Lupus, v. 31, n. 8, p. 974-984, 2022Tradução . . Disponível em: https://doi.org/10.1177/09612033221102073. Acesso em: 04 set. 2024.
APA
Signorelli, F., Balbi, G. G. M., Aikawa, N. E., Silva, C. A. A. da, Kupa, L. de V. K., Medeiros-Ribeiro, A. C., et al. (2022). Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. Lupus, 31( 8), 974-984. doi:10.1177/09612033221102073
NLM
Signorelli F, Balbi GGM, Aikawa NE, Silva CAA da, Kupa L de VK, Medeiros-Ribeiro AC, Yuki EFN, Pasoto SG, Saad CGS, Borba Neto EF, Bonfa ESD de O. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome [Internet]. Lupus. 2022 ; 31( 8): 974-984.[citado 2024 set. 04 ] Available from: https://doi.org/10.1177/09612033221102073
Vancouver
Signorelli F, Balbi GGM, Aikawa NE, Silva CAA da, Kupa L de VK, Medeiros-Ribeiro AC, Yuki EFN, Pasoto SG, Saad CGS, Borba Neto EF, Bonfa ESD de O. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome [Internet]. Lupus. 2022 ; 31( 8): 974-984.[citado 2024 set. 04 ] Available from: https://doi.org/10.1177/09612033221102073
Artigo de periodico
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients (2022)
Gualano, Bruno ; Saad, Carla G. S; Sieczkowska, Sofia Mendes ; Lemes, Ítalo Ribeiro ; Silva, Rafael Pires da ; Pinto, Ana Jéssica ; Mazzolani, Bruna Caruso ; Smaira, Fabiana Infante ; Gil, Saulo ; Oliveira Junior, Gersiel ; Aikawa, Nadia Emi ; Medeiros-Ribeiro, Ana C ; Silva, Clovis A ; Yuki, Emily F. N ; Pasoto, Sandra Gofinet ; Pereira, Rosa Maria Rodrigues ; Shinjo, Samuel Katsuyuki ; Andrade, Danieli Castro Oliveira de ; Sampaio-Barros, Percival ; Roschel, Hamilton ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Journal of applied physiology. Unidades: FM, EEFE
Subjects: COVID-19, FÁRMACOS IMUNOSSUPRESSORES, ATIVIDADE FÍSICA, EXERCÍCIOS DE RESISTÊNCIA MUSCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUALANO, Bruno et al. Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients. Journal of applied physiology, v. 132, n. 3, p. 682-688, 2022Tradução . . Disponível em: https://doi.org/10.1152/japplphysiol.00015.2022. Acesso em: 04 set. 2024.
APA
Gualano, B., Saad, C. G. S., Sieczkowska, S. M., Lemes, Í. R., Silva, R. P. da, Pinto, A. J., et al. (2022). Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients. Journal of applied physiology, 132( 3), 682-688. doi:10.1152/japplphysiol.00015.2022
NLM
Gualano B, Saad CGS, Sieczkowska SM, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Gil S, Oliveira Junior G, Aikawa NE, Medeiros-Ribeiro AC, Silva CA, Yuki EFN, Pasoto SG, Pereira RMR, Shinjo SK, Andrade DCO de, Sampaio-Barros P, Roschel H, Bonfa ESD de O. Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients [Internet]. Journal of applied physiology. 2022 ; 132( 3): 682-688.[citado 2024 set. 04 ] Available from: https://doi.org/10.1152/japplphysiol.00015.2022
Vancouver
Gualano B, Saad CGS, Sieczkowska SM, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Gil S, Oliveira Junior G, Aikawa NE, Medeiros-Ribeiro AC, Silva CA, Yuki EFN, Pasoto SG, Pereira RMR, Shinjo SK, Andrade DCO de, Sampaio-Barros P, Roschel H, Bonfa ESD de O. Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients [Internet]. Journal of applied physiology. 2022 ; 132( 3): 682-688.[citado 2024 set. 04 ] Available from: https://doi.org/10.1152/japplphysiol.00015.2022
Artigo de periodico
Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients (2022)
Gualano, Bruno ; Lemes, Ítalo Ribeiro ; Silva, Rafael Pires da ; Pinto, Ana Jessica ; Mazzolani, Bruna Caruso ; Smaira, Fabiana Infante ; Sieczkowska, Sofia Mendes ; Aikawa, Nadia Emi ; Pasoto, Sandra Gofinet ; Medeiros-Ribeiro, Ana Cristina ; Saad, Carla; Yuki, Emily F. N ; Silva, Clovis Artur ; Swinton, Paul Alan ; Hallal, Pedro Curi ; Roschel, Hamilton ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Scandinavian journal of medicine & science in sports. Unidades: FM, EEFE
Subjects: DOENÇAS AUTOIMUNES, DOENÇAS REUMÁTICAS, COVID-19, IMUNOSSUPRESSÃO, ATIVIDADE FÍSICA, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUALANO, Bruno et al. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients. Scandinavian journal of medicine & science in sports, v. 32, n. 10, p. 1510-1515, 2022Tradução . . Disponível em: https://doi.org/10.1111/sms.14213. Acesso em: 04 set. 2024.
APA
Gualano, B., Lemes, Í. R., Silva, R. P. da, Pinto, A. J., Mazzolani, B. C., Smaira, F. I., et al. (2022). Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients. Scandinavian journal of medicine & science in sports, 32( 10), 1510-1515. doi:10.1111/sms.14213
NLM
Gualano B, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad C, Yuki EFN, Silva CA, Swinton PA, Hallal PC, Roschel H, Bonfa ESD de O. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients [Internet]. Scandinavian journal of medicine & science in sports. 2022 ; 32( 10): 1510-1515.[citado 2024 set. 04 ] Available from: https://doi.org/10.1111/sms.14213
Vancouver
Gualano B, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad C, Yuki EFN, Silva CA, Swinton PA, Hallal PC, Roschel H, Bonfa ESD de O. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients [Internet]. Scandinavian journal of medicine & science in sports. 2022 ; 32( 10): 1510-1515.[citado 2024 set. 04 ] Available from: https://doi.org/10.1111/sms.14213

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em